Status:
COMPLETED
INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya
Lead Sponsor:
Elizabeth Glaser Pediatric AIDS Foundation
Collaborating Sponsors:
UNITAID
Kenya Ministry of Health
Conditions:
COVID-19
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
Integration of antigen-detecting rapid diagnostic tests (Ag-RDT) for COVID-19 into services that provide care for vulnerable populations such as pregnant women, children, people with HIV infection, an...
Detailed Description
Rationale: The use of simple, rapid and affordable antigen-detecting rapid diagnostic tests (Ag-RDT) to expand access to SARS-CoV-2 testing is being incorporated in many national COVID-19 response pla...
Eligibility Criteria
Inclusion
- Age ≥ 2 years.
- Identified as SARS-CoV-2 positive during the study.
- Willing and able to provide informed consent or parental consent +/- assent for the study participation according to the national guidelines
Exclusion
- • Significant medical or psychological condition that would preclude active study participation or ability to provide informed consent.
Key Trial Info
Start Date :
May 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
152082 Patients enrolled
Trial Details
Trial ID
NCT05382130
Start Date
May 17 2022
End Date
March 31 2023
Last Update
January 11 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Health facilities in Cameroon
Yaoundé, Cameroon
2
Health facilities in Kenya
Nairobi, Kenya